Trajectories of individual symptoms in remitters versus non-remitters with depression

Journal of Affective Disorders

Volumn 151, Issue 2, 2013, Pages 506-513

  Sakurai, Hitoshi ^a   Uchida, Hiroyuki ^a,b   Abe, Takayuki ^a   Nakajima, Shinichiro ^a,b,c   Suzuki, Takefumi ^a   Pollock, Bruce G ^b,c   Sato, Yuji ^a   Mimura, Masaru ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Depression; Major depressive disorder; Prediction; Remission

Indexed keywords

CITALOPRAM;

ADULT; AGED; APPETITE; ARTICLE; DECISION MAKING; EMOTION; ENERGY; FEMALE; HUMAN; HYPERSOMNIA; ILLNESS TRAJECTORY; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL CONCENTRATION; MOOD; OUTPATIENT; PATIENT PARTICIPATION; PRIORITY JOURNAL; REMISSION; RESTLESSNESS; SELF CONCEPT; SELF REPORT; SUICIDAL IDEATION; SYMPTOM; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT CHANGE;

DEPRESSION; MAJOR DEPRESSIVE DISORDER; PREDICTION; REMISSION;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885474874     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.06.035     Document Type: Article

References (32)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC.
2. P. Bech, L.F. Gram, E. Dein, O. Jacobsen, J. Vitger, and T.G. Bolwig Quantitative rating of depressive states Acta Psychiatrica Scandinavica 51 1975 161 170
3. D. Faries, J. Herrera, J. Rayamajhi, D. DeBrota, M. Demitrack, and W.Z. Potter The responsiveness of the Hamilton Depression Rating Scale Journal of Psychiatric Research 34 2000 3 10
4. M. Fava Diagnosis and definition of treatment-resistant depression Biological Psychiatry 53 2003 649 659
5. R.D. Gibbons, D.C. Clark, and D.J. Kupfer Exactly what does the Hamilton Depression Rating Scale measure? Journal of Psychiatric Research 27 1993 259 273
6. D.S. Haskell, A. DiMascio, and B. Prusoff Rapidity of symptom reduction in depressions treated with amitriptyline Journal of Nervous and Mental Disease 160 1975 24 33
7. F. Holsboer Antidepressant drug discovery in the postgenomic era World Journal of Biological Psychiatry 2 2001 165 177
8. A.M. Hunter, B.O. Muthen, I.A. Cook, and A.F. Leuchter Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder Journal of Psychiatric Research 44 2010 90 98
9. M. Jackowska, S. Dockray, H. Hendrickx, and A. Steptoe Psychosocial factors and sleep efficiency: discrepancies between subjective and objective evaluations of sleep Psychosomatic Medicine 73 2011 810 816
10. M.M. Katz, S.H. Koslow, and A. Frazer Onset of antidepressant activity: reexamining the structure of depression and multiple actions of drugs Depression and Anxiety 4 1996 257 267
11. M.M. Katz, S.H. Koslow, J.W. Maas, A. Frazer, C.L. Bowden, R. Casper, J. Croughan, J. Kocsis, and E. Redmond Jr. The timing, specificity and clinical prediction of tricyclic drug effects in depression Psychological Medicine 17 1987 297 309
12. M.M. Katz, S.H. Koslow, J.W. Maas, A. Frazer, J. Kocsis, S. Secunda, C.L. Bowden, and R.C. Casper Identifying the specific clinical actions of amitriptyline: interrelationships of behaviour, affect and plasma levels in depression Psychological Medicine 21 1991 599 611
13. M.M. Katz, J.L. Tekell, C.L. Bowden, S. Brannan, J.P. Houston, N. Berman, and A. Frazer Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression Neuropsychopharmacology 29 2004 566 579
14. W. Maier, M. Philipp, and A. Gerken Dimensions of the Hamilton Depression Scale. Factor analysis studies European Archives of Psychiatry and Neurological Sciences 234 1985 417 422
15. S.M. McClintock, M.M. Husain, S.R. Wisniewski, A.A. Nierenberg, J.W. Stewart, M.H. Trivedi, I. Cook, D. Morris, D. Warden, and A.J. Rush Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication Journal of Clinical Psychopharmacology 31 2011 180 186
16. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change British Journal of Psychiatry 134 1979 382 389
17. S. Nakajima, T. Suzuki, K. Watanabe, H. Kashima, and H. Uchida Accelerating response to antidepressant treatment in depression: a review and clinical suggestions Progess in Neuro-Psychopharmacology and Biological Psychiatry 34 2010 259 264
18. A.A. Nierenberg, M.M. Husain, M.H. Trivedi, M. Fava, D. Warden, S.R. Wisniewski, S. Miyahara, and A.J. Rush Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report Psychological Medicine 40 2010 41 50
19. A.A. Nierenberg, N.E. McLean, J.E. Alpert, J.J. Worthington, J.F. Rosenbaum, and M. Fava Early nonresponse to fluoxetine as a predictor of poor 8-week outcome American Journal of Psychiatry 152 1995 1500 1503
20. A.J. Rush, M. Fava, S.R. Wisniewski, P.W. Lavori, M.H. Trivedi, H.A. Sackeim, M.E. Thase, A.A. Nierenberg, F.M. Quitkin, T.M. Kashner, D.J. Kupfer, J.F. Rosenbaum, J. Alpert, J.W. Stewart, P.J. McGrath, M.M. Biggs, K. Shores-Wilson, B.D. Lebowitz, L. Ritz, and G. Niederehe Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design Controlled Clinical Trials 25 2004 119 142
21. A.J. Rush, D.E. Giles, R.B. Jarrett, F. Feldman-Koffler, J.R. Debus, J. Weissenburger, P.J. Orsulak, and H.P. Roffwarg Reduced REM latency predicts response to tricyclic medication in depressed outpatients Biological Psychiatry 26 1989 61 72
22. A.J. Rush, M.H. Trivedi, S.R. Wisniewski, A.A. Nierenberg, J.W. Stewart, D. Warden, G. Niederehe, M.E. Thase, P.W. Lavori, B.D. Lebowitz, P.J. McGrath, J.F. Rosenbaum, H.A. Sackeim, D.J. Kupfer, J. Luther, and M. Fava Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report American of Journal of Psychiatry 163 2006 1905 1917
23. R.C. Shelton, A. Prakash, C.H. Mallinckrodt, M.M. Wohlreich, J. Raskin, M.J. Robinson, and M.J. Detke Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression International Journal of Clinical Practice 61 2007 1337 1348
24. I.W. Schmidt, I.J. Berg, and B.G. Deelman Relations between subjective evaluations of memory and objective memory performance Perceptual and Motor Skills 93 2001 761 776
25. J.G. Small, V. Milstein, J.J. Kellams, and I.F. Small Comparative onset of improvement in depressive symptomatology with drug treatment, electroconvulsive therapy, and placebo Journal of Clinical Psychopharmacology 1 1981 62 69S
26. A. Szegedi, W.T. Jansen, A.P. van Willigenburg, E. van der Meulen, H.H. Stassen, and M.E. Thase Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients Journal of Clinical Psychiatry 70 2009 344 353
27. A. Szegedi, M.J. Muller, I. Anghelescu, C. Klawe, R. Kohnen, and O. Benkert Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression Journal of Clinical Psychiatry 64 2003 413 420
28. A. Tadic, I. Helmreich, R. Mergl, M. Hautzinger, R. Kohnen, V. Henkel, and U. Hegerl Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression Journal of Affective Disorders 120 2010 86 93
29. M.H. Trivedi, A.J. Rush, S.R. Wisniewski, A.A. Nierenberg, D. Warden, L. Ritz, G. Norquist, R.H. Howland, B. Lebowitz, P.J. McGrath, K. Shores-Wilson, M.M. Biggs, G.K. Balasubramani, and M. Fava Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice American Journal of Psychiatry 163 2006 28 40
30. N. Ueda, R. Yoshimura, K. Shinkai, and J. Nakamura Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression Pharmacopsychiatry 35 2002 175 181
31. R. Uher, A. Farmer, W. Maier, M. Rietschel, J. Hauser, A. Marusic, O. Mors, A. Elkin, R.J. Williamson, C. Schmael, N. Henigsberg, J. Perez, J. Mendlewicz, J.G. Janzing, A. Zobel, M. Skibinska, D. Kozel, A.S. Stamp, M. Bajs, A. Placentino, M. Barreto, P. McGuffin, and K.J. Aitchison Measuring depression: comparison and integration of three scales in the GENDEP study Psychological Medicine 38 2008 289 300
32. R. Uher, W. Maier, J. Hauser, A. Marusic, C. Schmael, O. Mors, N. Henigsberg, D. Souery, A. Placentino, M. Rietschel, A. Zobel, M. Dmitrzak-Weglarz, A. Petrovic, L. Jorgensen, P. Kalember, C. Giovannini, M. Barreto, A. Elkin, S. Landau, A. Farmer, K.J. Aitchison, and P. McGuffin Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression British Journal of Psychiatry 194 2009 252 259